Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme
Insulin degrading enzyme (IDE) has been detected in the cerebrospinal fluid media and plays a role in encapsulating and degrading the amyloid β (Aβ) monomer, thus regulating the levels of Aβ monomers. The current work illustrates a first study by which IDE encapsulates polymorphic early-stage Aβ oli...
Main Authors: | Karina Abramov-Harpaz, Yifat Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/12/1886 |
Similar Items
-
The Toxicity and Polymorphism of β-Amyloid Oligomers
by: Ya-ru Huang, et al.
Published: (2020-06-01) -
Concentration-dependent polymorphism of insulin amyloid fibrils
by: Andrius Sakalauskas, et al.
Published: (2019-12-01) -
The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design
by: Grazia Raffaella Tundo, et al.
Published: (2023-10-01) -
Amyloid-β Oligomers: Multiple Moving Targets
by: Dylan Shea, et al.
Published: (2022-04-01) -
Effect of silibinin and trans-chalcone in an Alzheimer's disease-like model generated by insulin amyloids
by: M. Omidi-Shahsavandi, et al.
Published: (2023-02-01)